217 related articles for article (PubMed ID: 9039111)
1. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Olson LJ; Knych ET; Herzig TC; Drewett JG
Hypertension; 1997 Jan; 29(1 Pt 2):254-61. PubMed ID: 9039111
[TBL] [Abstract][Full Text] [Related]
2. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
Li PL; Jin MW; Campbell WB
Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect.
Hanke CJ; Drewett JG; Myers CR; Campbell WB
Endocrinology; 1998 Oct; 139(10):4053-60. PubMed ID: 9751482
[TBL] [Abstract][Full Text] [Related]
4. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
5. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
6. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
7. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
8. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
Hussain AS; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
[TBL] [Abstract][Full Text] [Related]
9. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
Wegener JW; Closs EI; Förstermann U; Nawrath H
Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
[TBL] [Abstract][Full Text] [Related]
10. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
11. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
Zingarelli B; Haskó G; Salzman AL; Szabó C
Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
[TBL] [Abstract][Full Text] [Related]
12. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
Sobey CG; Faraci FM
Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
14. Blockade of nitrergic neuroeffector transmission in guinea-pig colon by a selective inhibitor of soluble guanylyl cyclase.
Olgart C; Hallén K; Wiklund NP; Iversen HH; Gustafsson LE
Acta Physiol Scand; 1998 Jan; 162(1):89-95. PubMed ID: 9492906
[TBL] [Abstract][Full Text] [Related]
15. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
[TBL] [Abstract][Full Text] [Related]
17. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide.
Teixeira CE; Priviero FB; Claudino MA; Baracat JS; De Nucci G; Webb RC; Antunes E
Eur J Pharmacol; 2006 Jan; 530(1-2):157-65. PubMed ID: 16371226
[TBL] [Abstract][Full Text] [Related]
19. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
20. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]